Myelofibrosis is a bone marrow disorder characterized by the replacement of blood-producing marrow tissue with fibrous connective tissue, resulting in reduced blood cell production and potential anemia, fatigue, and abnormal bleeding.
Hyperbaric oxygen therapy may potentially alleviate anemia in myelofibrosis patients by enhancing oxygen delivery to affected tissues, promoting bone marrow regeneration, and reducing inflammation.